Equation 1 · Comparing the Main Approaches to AI for Science and Medicine
What does this equation mean?
Read the formula alongside the article passage below. Each part has a deeper page with its role in the equation, the supporting passage and nearby citations.
This equation gives an approximation: it relates the quantities while allowing an approximation. Read the equation part by part below; each part has a contextual explanation and a link to its mathematical background.
Read it piece by piece
Symbol hatN_hits
hatits is a part of this expression. Its role is fixed by the surrounding article and by the operations shown in the formula.
Symbol s
s appears in the bound of this sum. The bound states where the repeated operation starts, ends, or which values it includes.
Symbol h
the hit rate measured directly among compounds actually synthesized and tested at docking-score bin s.
subscript
The lower label selects a particular version, component, or indexed member of the quantity. For example, x₀ and xₜ can be values at different positions.
Starting index or lower bound: s
This label says where the repeated addition, multiplication, or accumulation starts. Read its value or condition together with the article’s description of the index.
How to interpret it
Its accuracy depends on the assumptions and range of use described in the article.
What the article says around this equation
High-throughput virtual screening takes the opposite approach: rather than proposing new compositions, it exhaustively scores a library that already exists. The clearest demonstration is ultra-large library docking, in which researchers computationally docked a library of 170 million make-on-demand compounds, built from 130 well-characterized reactions, against two protein targets: AmpC beta-lactamase and the D4 dopamine receptor [ 8 ] . Against AmpC, 99 million library members were scored, 51 top-ranked compounds were selected and 44 synthesized, yielding an 11% hit rate and, after optimization, a 77-nanomolar inhibitor among the most potent non-covalent AmpC inhibitors then known. Against…
Read the full surrounding passage
High-throughput virtual screening takes the opposite approach: rather than proposing new compositions, it exhaustively scores a library that already exists. The clearest demonstration is ultra-large library docking, in which researchers computationally docked a library of 170 million make-on-demand compounds, built from 130 well-characterized reactions, against two protein targets: AmpC beta-lactamase and the D4 dopamine receptor [ 8 ] . Against AmpC, 99 million library members were scored, 51 top-ranked compounds were selected and 44 synthesized, yielding an 11% hit rate and, after optimization, a 77-nanomolar inhibitor among the most potent non-covalent AmpC inhibitors then known. Against D4, 138 million compounds were scored, 589 selected and 549 synthesized, and 122 bound the receptor — a hit rate that fell roughly monotonically as docking score worsened. That monotonic relationship is itself the interesting result, because it let the authors extrapolate a library-wide estimate rather than test everything directly: . where h(s) is the hit rate measured directly among compounds actually synthesized and tested at docking-score bin s , and N(s) is the number of untested library members scored into that bin. Applying this to the D4 results produced an estimate of roughly 453,000 ligands across the full 138-million-compound library — a projection under an assumed score-to-hit-rate relationship, not a directly counted total. Confirmed hits included a 180-picomolar, subtype-selective D4 agonist, one of 81 new chemotypes with no prior literature precedent, 30 of which showed submicromolar activity. This is screening logic, not generative logic: nothing here proposes a molecule outside the pre-enumerated library, and the achievement is exhaustive search of a known space rather than invention of a new one.
Sources cited in the surrounding passage
These citations give research context. Read each source to check which claims it supports.
Return to Comparing the Main Approaches to AI for Science and Medicine